⌘K

Login Start Free

Home/Filings/4/0001213900-22-081479

4//SEC Filing

Shenouda Maged 4

Accession 0001213900-22-081479

CIK 0001553643other

View on SEC.gov Company Profile

Filed

Dec 19, 7:00 PM ET

Accepted

Dec 20, 5:34 PM ET

Size

5.4 KB

Accession

0001213900-22-081479

Insider Transaction Report

Form 4

Period: 2022-12-16

RELMADA THERAPEUTICS, INC.RLMD

Chief Financial Officer

Transactions

Award
Stock Option (right to buy)
2022-12-16+194,917→ 194,917 total
Exercise: $3.37From: 2023-03-16Exp: 2032-12-16→ Common Stock (194,917 underlying)

Footnotes (1)

[F1]62,560 of the shares are immediately vested; 132,357 shares vest in 16 equal quarterly installments commencing on March 16, 2023.

Documents

1 file

4
ownership.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

RELMADA THERAPEUTICS, INC.

CIK 0001553643

Entity typeother

Related Parties

1

filerCIK 0001658369

Filing Metadata

Form type: 4
Filed: Dec 19, 7:00 PM ET
Accepted: Dec 20, 5:34 PM ET
Size: 5.4 KB

View on SEC.gov